{
  "variants": [
    {
      "variant": "K27N",
      "gene": "PARKIN",
      "protein_change": "K27N",
      "variant_string_id": "PARKIN_K27N",
      "flowchart_steps": {
        "step_1": {
          "description": "The paper establishes that Parkin's Uld domain interacts with Rpn10, and structural instability in this domain is linked to AR-JP pathogenesis.",
          "result": "Yes"
        },
        "step_2": {
          "description": "X-ray crystallography and MD simulations assess structural changes in wild-type vs. mutant Uld, aligning with the disease mechanism.",
          "result": "Yes"
        },
        "step_3a": {
          "description": "Controls (wild-type Uld and mutants) are used, but replicates are not explicitly mentioned.",
          "result": "No"
        },
        "step_3b": {
          "description": "No known pathogenic/benign variant controls are used; the study focuses on novel mutants.",
          "result": "No"
        },
        "step_3c": {
          "description": "No variant controls (pathogenic/benign) are explicitly used in the assays.",
          "result": "No"
        },
        "step_4a": {
          "description": "No statistical analysis or OddsPath values are reported.",
          "result": "No"
        },
        "step_4b": {
          "description": "0 pathogenic/benign variant controls used in the study.",
          "result": "Max PS3_supporting / Max BS3_supporting"
        }
      },
      "evidence_strength": "PS3_supporting"
    },
    {
      "variant": "R33Q",
      "gene": "PARKIN",
      "protein_change": "R33Q",
      "variant_string_id": "PARKIN_R33Q",
      "flowchart_steps": {
        "step_1": {
          "description": "The paper establishes that Parkin's Uld domain interacts with Rpn10, and structural instability in this domain is linked to AR-JP pathogenesis.",
          "result": "Yes"
        },
        "step_2": {
          "description": "X-ray crystallography and MD simulations assess structural changes in wild-type vs. mutant Uld, aligning with the disease mechanism.",
          "result": "Yes"
        },
        "step_3a": {
          "description": "Controls (wild-type Uld and mutants) are used, but replicates are not explicitly mentioned.",
          "result": "No"
        },
        "step_3b": {
          "description": "No known pathogenic/benign variant controls are used; the study focuses on novel mutants.",
          "result": "No"
        },
        "step_3c": {
          "description": "No variant controls (pathogenic/benign) are explicitly used in the assays.",
          "result": "No"
        },
        "step_4a": {
          "description": "No statistical analysis or OddsPath values are reported.",
          "result": "No"
        },
        "step_4b": {
          "description": "0 pathogenic/benign variant controls used in the study.",
          "result": "Max PS3_supporting / Max BS3_supporting"
        }
      },
      "evidence_strength": "PS3_supporting"
    },
    {
      "variant": "R42P",
      "gene": "PARKIN",
      "protein_change": "R42P",
      "variant_string_id": "PARKIN_R42P",
      "flowchart_steps": {
        "step_1": {
          "description": "The paper establishes that Parkin's Uld domain interacts with Rpn10, and structural instability in this domain is linked to AR-JP pathogenesis.",
          "result": "Yes"
        },
        "step_2": {
          "description": "X-ray crystallography and MD simulations assess structural changes in wild-type vs. mutant Uld, aligning with the disease mechanism.",
          "result": "Yes"
        },
        "step_3a": {
          "description": "Controls (wild-type Uld and mutants) are used, but replicates are not explicitly mentioned.",
          "result": "No"
        },
        "step_3b": {
          "description": "No known pathogenic/benign variant controls are used; the study focuses on novel mutants.",
          "result": "No"
        },
        "step_3c": {
          "description": "No variant controls (pathogenic/benign) are explicitly used in the assays.",
          "result": "No"
        },
        "step_4a": {
          "description": "No statistical analysis or OddsPath values are reported.",
          "result": "No"
        },
        "step_4b": {
          "description": "0 pathogenic/benign variant controls used in the study.",
          "result": "Max PS3_supporting / Max BS3_supporting"
        }
      },
      "evidence_strength": "PS3_supporting"
    },
    {
      "variant": "V56E",
      "gene": "PARKIN",
      "protein_change": "V56E",
      "variant_string_id": "PARKIN_V56E",
      "flowchart_steps": {
        "step_1": {
          "description": "The paper establishes that Parkin's Uld domain interacts with Rpn10, and structural instability in this domain is linked to AR-JP pathogenesis.",
          "result": "Yes"
        },
        "step_2": {
          "description": "X-ray crystallography and MD simulations assess structural changes in wild-type vs. mutant Uld, aligning with the disease mechanism.",
          "result": "Yes"
        },
        "step_3a": {
          "description": "Controls (wild-type Uld and mutants) are used, but replicates are not explicitly mentioned.",
          "result": "No"
        },
        "step_3b": {
          "description": "No known pathogenic/benign variant controls are used; the study focuses on novel mutants.",
          "result": "No"
        },
        "step_3c": {
          "description": "No variant controls (pathogenic/benign) are explicitly used in the assays.",
          "result": "No"
        },
        "step_4a": {
          "description": "No statistical analysis or OddsPath values are reported.",
          "result": "No"
        },
        "step_4b": {
          "description": "0 pathogenic/benign variant controls used in the study.",
          "result": "Max PS3_supporting / Max BS3_supporting"
        }
      },
      "evidence_strength": "PS3_supporting"
    }
  ]
}